Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Researchers from Shandong University publish new studies and findings in the area of vaccines
July 9th, 2008
New investigation results, 'Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination,' are detailed in a study published in Journal of Virological Methods. According to a study from Jinan, People's Republic of China, "Diseases associated with porcine circovirus type 2 (PCV2) infections are becoming a major problem for the swine industry worldwide. The capsid protein (Cap) of PCV2 is an antigen important for both early diagnosis and development of vaccines." "In this study, Lactococcus lactis was used as vehicle to deliver the PCV2 antigen in an attempt to develop oral vaccine. A cap gene with a deleted nuclear...
Source: Vaccine Weekly (2008-07-09)
|
